FTC Moves to Block $3.5 Billion Veterinary Supply Merger

The legal challenge, brought by the Federal Trade Commission alongside California Attorney General Rob Bonta and New York Attorney General Letitia James, targets a proposed combination of the nation’s two largest veterinary supply distributors, according to a Nov. 13 report published by Forth.

Regulators contend that the transaction would create a dominant distributor controlling more than half of the US veterinary supply market, potentially giving the combined business greater leverage over pricing and distribution services.

The lawsuit raises concerns that reduced competition could translate into higher operating expenses for veterinary practices, with some of those costs ultimately passed on to consumers seeking medical care for their pets.

Market Concentration Draws Antitrust Scrutiny

The proposed acquisition would eliminate a major competitor in the distribution of veterinary products, a business that supports animal hospitals and clinics by supplying medications, medical equipment and other essential products.

According to Forth’s summary of statements from federal and state authorities, regulators argue that the loss of direct competition between Covetrus and MWI could undermine pricing discipline and weaken incentives to maintain service standards.

The complaint alleges that the transaction would violate federal competition laws, including the Clayton Act and the Federal Trade Commission Act.

Authorities also raised concerns extending beyond prices. The proposed consolidation could make veterinary practices more dependent on a single major supplier, potentially increasing exposure to distribution disruptions and product shortages, according to the regulatory allegations summarized by Forth.

Read more: Veterinary Accreditor Defeats Antitrust Challenge From Tennessee University

Such risks could have consequences for veterinary clinics that rely on dependable access to supplies to maintain routine operations and deliver timely care.

Court Order Temporarily Halts Transaction

The regulatory challenge has already resulted in a temporary restraining order preventing the transaction from moving forward, according to Forth.

The FTC and participating state authorities are seeking a preliminary injunction that would keep the acquisition on hold while the legal dispute proceeds.

The action represents an effort by federal and state enforcers to intervene before the proposed merger is completed, rather than address potential competitive harm after the two businesses have combined.

The allegations remain subject to judicial review, and the filing of the lawsuit does not establish that the transaction violates antitrust law.

Private Equity Ownership Adds Corporate Dimension

The proposed transaction also involves major private equity investors.

According to the FTC announcement reproduced by Forth, Covetrus is owned by investment firms Clayton, Dubilier & Rice and TPG. The acquisition would involve purchasing MWI from its parent company, Cencora.

The ownership structure places the transaction within the broader debate over consolidation in industries providing essential health-related services, including the role of financial investors in businesses serving medical professionals.

The regulators’ central concern, however, is the potential reduction in competition between distributors rather than private equity ownership itself.

Veterinary Practices Face Uncertainty

For veterinary providers, the dispute highlights the importance of competition among companies responsible for delivering medical supplies and related services.

Regulators maintain that allowing the two leading distributors to combine could leave clinics with fewer alternatives when negotiating prices, choosing suppliers or responding to disruptions.

The potential impact on pet owners would largely depend on whether higher procurement and distribution costs were passed through to veterinary service prices.

Source: Forth